HCW Biologics Inc Financial Flexibility Index

Latest as of June 2026: -0.21x

HCW Biologics Inc financial flexibility index. HCW Biologics Inc (HCWB) has a Financial Flexibility Index of -0.21x as of June 2026. Free cash flow of $-3.97 Million (operating CF $-3.97 Million minus capex $4.00) represents 0% of total liabilities ($19.34 Million).

Financial Flexibility Index

-0.21x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-3.97 Million
Operating CF − Capex

Total Liabilities

$19.34 Million
USD

Capital Expenditures

$4.00
USD

Financial Flexibility Index of HCW Biologics Inc (2019–2025)

Financial flexibility index of HCW Biologics Inc from 2019 to 2025. Historical Financial Flexibility Index trend for HCW Biologics Inc across 7 annual periods. Check how high is HCW Biologics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.

HCW Biologics Inc Financial Flexibility Index by Year (2019–2025)

HCW Biologics Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for HCW Biologics Inc. For the full cash flow conversion analysis, see HCW Biologics Inc (HCWB) cash flow conversion.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.62x $-13.39 Million $-13.39 Million $21.76 Million ▼ -63.1%
2024 -0.38x $-13.97 Million $-14.23 Million $37.01 Million ▲ +65.2%
2023 -1.08x $-16.31 Million $-22.51 Million $15.05 Million ▼ -9059.7%
2022 -0.01x $-110.98K $-10.39 Million $9.38 Million ▲ +99.7%
2021 -4.71x $-10.93 Million $-10.98 Million $2.32 Million ▲ +54.0%
2020 -10.23x $-10.24 Million $-10.43 Million $1.00 Million ▼ -105.7%
2019 -4.98x $-5.30 Million $-6.77 Million $1.07 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities